Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypnosis in Internal Medecine (HypnoMedIn)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04698824
Recruitment Status : Not yet recruiting
First Posted : January 7, 2021
Last Update Posted : May 5, 2021
Sponsor:
Collaborator:
Groupe Hospitalier Mutualiste de Grenoble
Information provided by (Responsible Party):
University Hospital, Grenoble

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Description of the short and long-term impact of hypnosis sessions for patient having benefited from at least one hypnosis session in internal medicine at the french hospital "Groupe Hospitalier Mutualiste de Grenoble", with the help of a qualitative survey made by phone.

Condition or disease Intervention/treatment
Hypnosis Autoimmune Diseases Medically Unexplained Symptoms Procedure: Hypnosis session

Detailed Description:

The practice of hypnosis has experienced a recent boom in medicine, with a multiplication of its fields of action. Regarding internal medicine, the influence of the psyche on the immune system makes the use of hypnosis particularly relevant for autoimmune diseases. Medically unexplained symptoms (another important field of internal medicine) are also strongly psychosomatic and thus susceptible to hypnosis. The hypothesis is thus made that hypnosis can bring multiple benefits to internal medicine patients.

The main objective of this study is to describe the short and long-term impact of hypnosis sessions for patient having benefited from at least one hypnosis session in internal medicine at the french hospital "Groupe Hospitalier Mutualiste de Grenoble", with the help of a qualitative survey made by phone.

Moreover retrospective medical data concerning these patients will be collected to determine their medical history, their main symptoms et reasons to use hypnosis.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 70 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hypnose en médecine Interne
Estimated Study Start Date : June 2021
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : October 2021
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Procedure: Hypnosis session
    At least one session of hypnosis in the internal medicine unit at the hospital "Groupe Hospitalier Mutualiste de Grenoble"

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Description of the short and long-term impact of hypnosis sessions thanks to a qualitative phone survey [ Time Frame: Assessed only once. Phone call will be performed between march 2021 and June 2021 ]
    Improvement in symptoms and quality of life, assessed thanks to a qualitative phone survey by 5-levels Likert scales


Secondary Outcome Measures :
  1. Assessment of the reasons for patient satisfaction / dissatisfaction [ Time Frame: Assessed only once. Phone call will be performed between march 2021 and June 2021 ]
    Qualitative description by an open question in the phone survey

  2. Description of the characteristics of these patients and of the hypnosis sessions [ Time Frame: At inclusion ]
    Patients'characteristics described in medical records


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All consecutive patients who had at least one hypnosis session in internal medicine at the hospital "Groupe Hospitalier Mutualiste de Grenoble" between 08/28/2015 (date of the very first hypnosis consultation in internal medicine) and 03/17/2020 (date of confinement due to Covid19 in France)
Criteria

Inclusion Criteria:

  • All consecutive patients who had at least one hypnosis session in internal medicine at the hospital "Groupe Hospitalier Mutualiste de Grenoble" between 08/28/2015 (date of the very first hypnosis consultation in internal medicine) and 03/17/2020 (date of confinement due to Covid19 in France)

Exclusion Criteria:

  • Patient who had a hypnosis session, but who is not followed for a pathology in internal medicine or in internal medicine with a pneumological orientation
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04698824


Contacts
Layout table for location contacts
Contact: Maxime LUGOSI, PhD 04 76 76 37 07 mlugosi@chu-grenoble.fr
Contact: Mélanie ARNAUD marnaud3@chu-grenoble.fr

Sponsors and Collaborators
University Hospital, Grenoble
Groupe Hospitalier Mutualiste de Grenoble
Investigators
Layout table for investigator information
Principal Investigator: Maxime LUGOSI, PhD CHU Grenoble Alpes
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: University Hospital, Grenoble
ClinicalTrials.gov Identifier: NCT04698824    
Other Study ID Numbers: 2020-A03469-30
First Posted: January 7, 2021    Key Record Dates
Last Update Posted: May 5, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Grenoble:
internal medicine
survey
qualitative
impact of hypnosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Autoimmune Diseases
Medically Unexplained Symptoms
Immune System Diseases